Not applicableLooking for participantsNCT05046444What this trial is testingSolving Riddles Through SequencingWho this might be right forLeukemiaHematologic MalignancyRare Diseases+3 more Munich Leukemia Laboratory 100
Not applicableUnknownNCT06100081What this trial is testingReal-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and NeckWho this might be right forUnknown Primary TumorsOropharynx Cancer University Medical Center Groningen 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06578871What this trial is testingSurgery and Reducing Ionizing Radiation of the Unknown PrimaryWho this might be right forHead and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Not applicableActive Not RecruitingNCT04151134What this trial is testingEvaluation of Tongue Base MucOsectomy & Step sErial SectioningWho this might be right forSquamous Cell Carcinoma of the Oropharynx Royal Marsden NHS Foundation Trust 100
Not applicableStudy completedNCT04750109What this trial is testingCarcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid BiomarkersWho this might be right forCancer of Unknown Primary Site The Christie NHS Foundation Trust 117
Not applicableActive Not RecruitingNCT06863870What this trial is testingAssessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous MelanomaWho this might be right forMelanoma Neoplasms IRCCS Azienda Ospedaliero-Universitaria di Bologna 35
Testing effectiveness (Phase 2)Study completedNCT03422536What this trial is testingFiclatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more University of Arizona 78
Not applicableStudy completedNCT00745381What this trial is testingA Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsWho this might be right forGastric CancerPancreatic Cancer Memorial Sloan Kettering Cancer Center 238
Testing effectiveness (Phase 2)Ended earlyNCT00201734What this trial is testingCapecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryWho this might be right forTumorsUnknown Primary TumorsAdenocarcinoma Ohio State University Comprehensive Cancer Center 57
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Not applicableLooking for participantsNCT04475640What this trial is testingCancer Genetic Testing in Ethnic PopulationsWho this might be right forBreast CarcinomaCarcinoma of Unknown PrimaryCentral Nervous System Carcinoma+8 more Mayo Clinic 1,800
Testing effectiveness (Phase 2)Study completedNCT00117442What this trial is testingCarboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole BloodWho this might be right forBreast CancerLung CancerOvarian Cancer Amgen 61
Not applicableLooking for participantsNCT06140992What this trial is testingPaCIFiC-CUP Classifies Cancer of Unknown PrimaryWho this might be right forUnknown Primary TumorsDNA Methylation Sun Yat-sen University 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT02820857What this trial is testingAssessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary CancerWho this might be right forNeuroendocrine Carcinomas Hospices Civils de Lyon 153
Very early researchActive Not RecruitingNCT04544098What this trial is testingLutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the LiverWho this might be right forNeuroendocrine TumorsLiver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03396471What this trial is testingStudy of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown PrimaryWho this might be right forCarcinoma, Unspecified Site Hoosier Cancer Research Network 14
Testing effectiveness (Phase 2)Looking for participantsNCT06636734What this trial is testingLovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialWho this might be right forClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more Emory University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07434180What this trial is testingPhase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown PrimaryWho this might be right forCancer of Unknown Primary Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)Looking for participantsNCT05172245What this trial is testingTesting the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerWho this might be right forClinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Carcinoma of Unknown Primary+24 more National Cancer Institute (NCI)